Inversion Tax Break Lives After Failed Pfizer Deal

Inversion Tax Break Lives After Failed Pfizer Deal Play

May 27 (Bloomberg) -- Bloomberg’s Peter Cook reports on the state of the inversion tax as Pfizer abandon’s plans to take over AstraZeneca in order to save taxes by moving operations overseas. He speaks on Bloomberg Television’s “In The Loop.”

  • On Air Now

    PAID PROGRAMMING Watch Now

  • Next

    PAID PROGRAMMING

blog comments powered by Disqus